FDA Wins Appeal On Drug Access For Terminally Ill Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
En banc review concludes there is no constitutional right to receive experimental drugs, reversing a previous ruling, but Abigail Alliance pledges to take case to the Supreme Court.
You may also be interested in...
Access To Investigational Drugs Under FDA Proposed Rule Depends On Size Of Treatment Group
Agency also details criteria for charging for investigational drugs in separate proposed rule.
US FDA’s ‘Bad Ad’ Program Snares Paragard Contraceptive TV Video Promo
CooperSurgical is hit with second letter for misleading promotion of its copper-containing intrauterine contraceptive. Video lacked any safety information, agency says in request for corrective communication.
COVID-19 Vaccine Manufacturers Are Not Enthusiastic About Using Defense Production Act
Pfizer and Moderna execs note they have sufficient resources with their partners to meet their vaccine production commitments. J&J, which has a manufacturing arrangement with Sanofi, is ready to ship four million doses of its vaccine upon receiving authorization from FDA.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: